• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高血压的易治与难治指南。

A guide for easy- and difficult-to-treat hypertension.

机构信息

Department of Nephrology and Hypertension, University Hospital Erlangen, Germany.

Cardiology Unit, Clinical and Molecular Medicine Department Sant'Andrea Hospital, Sapienza University of Rome, Rome, Italy; IRCCS Neuromed, Pozzilli, Italy.

出版信息

Int J Cardiol. 2014 Mar 1;172(1):17-22. doi: 10.1016/j.ijcard.2013.12.125. Epub 2014 Jan 4.

DOI:10.1016/j.ijcard.2013.12.125
PMID:24456885
Abstract

Although the blood pressure (BP) of many patients can be controlled using standard combinations, treatment of hypertension frequently represents a clinical challenge to the primary care physician. This article will review best practices for managing patients with easy- and difficult-to-treat hypertension, including preferred antihypertensive combinations, optimizing adherence and persistence, recognizing white-coat hypertension, and intensifying therapy for treatment-resistant patients. Each physician must decide based on his or her own level of experience at what point a patient becomes too challenging and would benefit from referral to a hypertension specialist for more intensive management and to complete the exclusion of secondary forms of arterial hypertension. With intensive pharmacotherapy, many patients with difficult-to-treat hypertension can achieve BP control. If it fails, interventional strategies (e.g., renal denervation) are a valid option to get BP controlled.

摘要

尽管许多患者的血压(BP)可以通过标准组合来控制,但高血压的治疗常常对初级保健医生构成临床挑战。本文将回顾管理易治性和难治性高血压患者的最佳实践,包括首选的降压联合治疗、优化依从性和持久性、识别白大衣高血压以及对治疗抵抗的患者强化治疗。每位医生都必须根据自己的经验水平来决定,在什么情况下患者变得过于棘手,需要转介给高血压专家进行更强化的管理,并彻底排除继发性高血压。通过强化药物治疗,许多难治性高血压患者可以实现血压控制。如果治疗失败,介入策略(如肾去神经术)是控制血压的有效选择。

相似文献

1
A guide for easy- and difficult-to-treat hypertension.高血压的易治与难治指南。
Int J Cardiol. 2014 Mar 1;172(1):17-22. doi: 10.1016/j.ijcard.2013.12.125. Epub 2014 Jan 4.
2
Renal denervation therapy for hypertension.用于治疗高血压的肾去神经支配疗法。
Circulation. 2013 Nov 12;128(20):2251-4. doi: 10.1161/CIRCULATIONAHA.113.004660.
3
[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].[介入性肾交感神经去神经术治疗高血压专家共识声明]
Dtsch Med Wochenschr. 2011 Nov;136(47):2418. doi: 10.1055/s-0031-1272580. Epub 2011 Nov 2.
4
Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study.肾交感神经去神经术对耐药性高血压患者糖代谢的影响:一项初步研究。
Circulation. 2011 May 10;123(18):1940-6. doi: 10.1161/CIRCULATIONAHA.110.991869. Epub 2011 Apr 25.
5
Resistant hypertension: a practical clinical approach.耐药性高血压:一种实用的临床方法。
J Hum Hypertens. 2013 Nov;27(11):657-62. doi: 10.1038/jhh.2013.34. Epub 2013 May 2.
6
Interventional approaches for resistant hypertension.介入治疗难治性高血压。
Curr Opin Nephrol Hypertens. 2012 Sep;21(5):475-80. doi: 10.1097/MNH.0b013e328356d004.
7
Renal denervation for hypertension: observations and predictions of a founder.肾去神经术治疗高血压:奠基人的观察与预测。
Eur Heart J. 2014 May;35(18):1178-85. doi: 10.1093/eurheartj/ehu091. Epub 2014 Mar 4.
8
Transcatheter renal denervation for the treatment of resistant arterial hypertension: the Swiss expert consensus.经导管去肾神经术治疗耐药性动脉高血压:瑞士专家共识。
Swiss Med Wkly. 2014 Mar 20;144:w13913. doi: 10.4414/smw.2014.13913.
9
[Primary and secondary (renovascular) arterial hypertension].[原发性和继发性(肾血管性)动脉高血压]
Dtsch Med Wochenschr. 2011 Jun;136(22):1187-90. doi: 10.1055/s-0031-1280537. Epub 2011 May 24.
10
Catheter-based renal denervation for treatment of resistant hypertension.基于导管的肾去神经术治疗顽固性高血压。
Dan Med J. 2012 Jun;59(6):A4439.

引用本文的文献

1
Renin angiotensin system inhibitors reduce the incidence of arterial thrombotic events in patients with hypertension and chronic myeloid leukemia treated with second- or third-generation tyrosine kinase inhibitors.血管紧张素转化酶抑制剂降低接受第二代或第三代酪氨酸激酶抑制剂治疗的高血压合并慢性髓性白血病患者的动脉血栓栓塞事件发生率。
Ann Hematol. 2020 Jul;99(7):1525-1530. doi: 10.1007/s00277-020-04102-6. Epub 2020 May 30.
2
Percutaneous Creation of a Central Iliac Arteriovenous Anastomosis for the Treatment of Arterial Hypertension.经皮创建中央髂动静脉吻合术治疗高血压。
Curr Hypertens Rep. 2018 Mar 19;20(3):18. doi: 10.1007/s11906-018-0816-8.
3
Global cardiovascular protection in chronic kidney disease.
慢性肾脏病中的全球心血管保护。
Nat Rev Cardiol. 2016 Oct;13(10):603-8. doi: 10.1038/nrcardio.2016.48. Epub 2016 Apr 7.
4
Understanding and treating hypertension in diabetic populations.了解和治疗糖尿病患者的高血压
Cardiovasc Diagn Ther. 2015 Oct;5(5):353-63. doi: 10.3978/j.issn.2223-3652.2015.06.02.
5
New Strategy to Control Blood Pressure: Interactive Mobile Phone Support.控制血压的新策略:交互式手机支持
J Clin Hypertens (Greenwich). 2016 Feb;18(2):109-10. doi: 10.1111/jch.12683. Epub 2015 Oct 14.
6
2015 Oman Heart Association guidelines for the management of hypertension : practical recommendations from the Oman Heart Association (OHA).《2015年阿曼心脏协会高血压管理指南:阿曼心脏协会(OHA)的实用建议》
High Blood Press Cardiovasc Prev. 2015 Mar;22(1):83-97. doi: 10.1007/s40292-014-0074-z. Epub 2014 Nov 18.